Your account is not claimed yet. You can sign up with ORCID to claim your account.

Lars Henrik Jensen (Lars H Jensen)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 26

Top Venues

Cancers

Journal of experimental & clinical cancer research : CR

Clinical case reports

Acta oncologica (Stockholm, Sweden)

University of Southern Denmark

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern Denmark Sep 1o 2014

Denmark

Associate Professor

Education History

University of Southern Denmark Feb 1o 2004 - Jan 31o 2007

Denmark

PHD

Publications

Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen-Lise Garm Spindler
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE study. Acta oncologica (Stockholm, Sweden) (2023)
Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafaelsen, Torben Frøstrup Hansen
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Louise Raunkilde, Torben Frøstrup Hansen, Birgitte Mayland Havelund, Caroline Emilie B Thomsen, Søren Rafael Rafaelsen, Jan Lindebjerg, Lars Henrik Jensen
Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study. Acta oncologica (Stockholm, Sweden) (2023)
Carine El Sissy, Amos Kirilovsky, Christine Lagorce Pagès, Florence Marliot, Petra A Custers, Edina Dizdarevic, Marine Sroussi, Mireia Castillo-Martin, Nacilla Haicheur, Mohamed Dermani, Nicolas Loche, Bénedicte Buttard, Ana Maria Musina, Maria-Gabriela Aniţei, José G van den Berg, Annegien Broeks, Soledad Iseas, Mariana Coraglio, Fernando Sanchez Loria, Alfredo Romero, Pierre Laurent-Puig, Aurélien de Reyniès, Laura M Fernandez, Karoui Medhi, David Tougeron, Carlos Alberto Vaccaro, Juan P Santino, Laurids Østergaard Poulsen, Jan Lindebjerg, Juan Manuel O'Connor, Viorel Scripcariu, Mihail-Gabriel Dimofte, Jean-Pierre Gerard, Myriam Chalabi, Nuno L Figueiredo, Rodrigo Oliva Perez, Angelita Habr-Gama, Jerome Galon, Torben Frøstrup Hansen, Lars Henrik Jensen, Geerard L O Beets, Guy Zeitoun, Franck Pagès
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafaelsen, Torben Frøstrup Hansen
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Liva K Stuhr, Kasper Madsen, Astrid Zedlitz Johansen, Inna Markovna Chen, Carsten Palnaes Hansen, Lars Henrik Jensen, Torben Frøstrup Hansen, Kirstine Kløve-Mogensen, Kaspar R Nielsen, Julia Sidenius Johansen
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers 15 (3) (2023)
Troels Dreier Christensen, Kasper Madsen, Emil Maag, Ole Larsen, Lars Henrik Jensen, Carsten Palnaes Hansen, Alice Markussen, Dan T S Høgdall, Inna Markovna Chen, Dorte Nielsen, Julia Sidenius Johansen
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. Cancers 15 (4) (2023)
Troels Dreier Christensen, Kasper Madsen, Emil Maag, Ole Larsen, Lars Henrik Jensen, Carsten Palnaes Hansen, Alice Markussen, Dan T S Høgdall, Inna Markovna Chen, Dorte Nielsen, Julia Sidenius Johansen
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. Cancers 15 (4) (2023)
Liva K Stuhr, Kasper Madsen, Astrid Zedlitz Johansen, Inna Markovna Chen, Carsten Palnaes Hansen, Lars Henrik Jensen, Torben Frøstrup Hansen, Kirstine Kløve-Mogensen, Kaspar R Nielsen, Julia Sidenius Johansen
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Cancers 15 (3) (2023)
Louise Faaborg, Rikke Fredslund Andersen, Sara Wc Wen, Caroline B Thomsen, Louise Raunkilde, Torben Frøstrup Hansen, Lars Henrik Jensen, Karina Dahl Steffensen, Anders Jakobsen
Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer. Future oncology (London, England) (2023)
Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafaelsen, Torben Frøstrup Hansen
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Troels Dreier Christensen, Kasper Madsen, Emil Maag, Ole Larsen, Lars Henrik Jensen, Carsten Palnaes Hansen, Alice Markussen, Dan T S Høgdall, Inna Markovna Chen, Dorte Nielsen, Julia Sidenius Johansen
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. Cancers 15 (4) (2023)
Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafaelsen, Torben Frøstrup Hansen
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Line Bechsgaard Andersen, Marit Sofie Kjær Mahler, Rikke Fredslund Andersen, Lars Henrik Jensen, Louise Raunkilde
The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab. Cancers 14 (19) (2022)
Louise Raunkilde, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Birgitte Mayland Havelund, Caroline Emilie B Thomsen, Lars Henrik Jensen
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer. Cancers 14 (18) (2022)
Mette Stie, Charlotte Delmar, Birgitte Noergaard, Lars Henrik Jensen
Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial. Cancers 14 (4) (2022)
Dorte Gilså Hansen, Theis Bitz Trabjerg, Jeffrey James Sisler, Jens Soendergaard, Lars Henrik Jensen
Cross-sectoral communication by bringing together patient with cancer, general practitioner and oncologist in a video-based consultation: a qualitative study of oncologists' and nurse specialists' perspectives. BMJ open 11 (5) (2021)
Robson Francisco Carvalho, Luisa Matos do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, Sílvia Regina Rogatto
Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. Cancers 13 (21) (2021)
Tonje Riise Hamre, Julie Kristine Stougaard, Birgitte Mayland Havelund, Lars Henrik Jensen, Torben Frøstrup Hansen
Re-exposure to immunotherapy in metastatic colon cancer: A case report. Clinical case reports 9 (6) (2021)
Kristian Blomberg, Torben Frøstrup Hansen, Claus Lohman Brasen, Jeppe B Madsen, Lars Henrik Jensen, Caroline Emilie B Thomsen
The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer. Cancers 13 (20) (2021)
Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Ploen, Jakob Eberhard, Jan Lindebjerg, Lars Henrik Jensen
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. International journal of cancer 149 (1) (2021)
Christina Therkildsen, Lars Henrik Jensen, Maria Rasmussen, Inge Bernstein
An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome. Clinical and experimental gastroenterology 14 (2021)
Alice Markussen, Lars Henrik Jensen, Laura Vittrup Diness, Finn Ole Larsen
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial. Cancers 12 (7) (2020)
Natacha Dencker Trabjerg, Christina Rask, Lars Henrik Jensen, Torben Frøstrup Hansen
Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report. Clinical case reports 7 (7) (2019)
Lars Henrik Jensen, René Olesen, Lone Noergaard Petersen, Anders Kindberg Boysen, Rikke Fredslund Andersen, Jan Lindebjerg, Lise Nottelmann, Caroline Emilie Brenner Thomsen, Birgitte Mayland Havelund, Anders Jakobsen, Torben Frøstrup Hansen
NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer. Cancers 11 (11) (2019)
Caroline Emilie B Thomsen, Ane Lindegaard Appelt, Rikke Fredslund Andersen, Jan Lindebjerg, Lars Henrik Jensen, Anders Jakobsen
The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer. Cancer medicine 6 (5) (2017)

Lars Henrik Jensen.css-eqlu8i{font-size:small;padding-left:4px;} (Lars H Jensen)

Publication Activity (10 Years)

Top Topics

Top Venues

Lars Henrik Jensen (Lars H Jensen)